Inventor · disambiguated record
Xiangzhu Wang
Also filed as: WANG XIANGZHU
71 granted patents·11 pending applications·1,283 citations·filing 2003–2024
99Inventor score
Files withACHILLION PHARMACEUTICALS INC70ACCUTAR BIOTECHNOLOGY INC2PHADKE AVINASH2WILES JASON ALLAN2ZHANG SUOMING2
Top patents by PatentIndex Score
82 records- 0199US10822352B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·20 cites·17 claims
- 0299US10550140B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·27 cites·20 claims
- 0399US10301336B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·27 cites·20 claims
- 0499US10287301B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·28 cites·18 claims
- 0599US10189869B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Jan 29, 2019·27 cites·36 claims
- 0699US10138225B2Amide compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Nov 27, 2018·33 cites·31 claims
- 0799US10106563B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·30 cites·20 claims
- 0899US10100072B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·27 cites·53 claims
- 0999US10092547B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·19 cites·14 claims
- 1099US10081645B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·27 cites·40 claims
- 1199US10011612B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jul 3, 2018·30 cites·3 claims
- 1299US10005802B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 26, 2018·27 cites·38 claims
- 1399US10000516B2Phosphonate compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 19, 2018·28 cites·28 claims
- 1499US9828396B2Alkyne compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·30 cites·40 claims
- 1599US9796741B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Oct 24, 2017·37 cites·50 claims
- 1699US9758537B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·27 cites·39 claims
- 1799US9732103B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·32 cites·29 claims
- 1899US9732104B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·30 cites·68 claims
- 1999US9695205B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·32 cites·56 claims
- 2099US9663543B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·32 cites·49 claims
- 2199US9598446B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·33 cites·7 claims
- 2298US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
- 2398US11407738B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·16 cites·12 claims
- 2498US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
- 2598US10919884B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 16, 2021·20 cites·12 claims
- 2698US10906887B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 2, 2021·20 cites·12 claims
- 2798US10689409B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·9 cites·23 claims
- 2898US10662175B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·20 claims
- 2998US10464956B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 5, 2019·21 cites·24 claims
- 3098US10428095B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 1, 2019·21 cites·2 claims
- 3198US10428094B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·21 cites·40 claims
- 3298US10370394B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·23 cites·35 claims
- 3398US10253053B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Apr 9, 2019·22 cites·20 claims
- 3498US10087203B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·25 cites·21 claims
- 3597US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
- 3697US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
- 3797US11001600B2Disubstituted compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 11, 2021·16 cites·9 claims
- 3897US10807952B2Compounds for treatment of immune inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·20 cites·13 claims
- 3997US10660876B2Amino compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·14 claims
- 4097US7906619B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·51 cites·28 claims
- 4196US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
- 4296US11648254B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signalingKUMQUAT BIOSCIENCES INC·Filed 2022·Granted May 16, 2023·7 cites·30 claims
- 4396US10092584B2Compounds for the treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Oct 9, 2018·28 cites·41 claims
- 4496US9273082B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·14 cites·17 claims
- 4595US12139497B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Nov 12, 2024·1 cites·20 claims
- 4695US11649229B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 4795US11649223B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 4895US10385097B2Ether compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Aug 20, 2019·23 cites·27 claims
- 4995US9125904B1Biphenyl imidazoles and related compounds useful for treating HCV infectionsWILES JASON ALLAN·Filed 2011·Granted Sep 8, 2015·17 cites·7 claims
- 5095US8809313B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsWILES JASON ALLAN·Filed 2012·Granted Aug 19, 2014·15 cites·32 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →